Scarica l'app Stockscreener
2.5305
0.82%
0.0205
Dopo l'orario di chiusura:
2.41
-0.1205
-4.76%
Precedente Chiudi:
$2.51
Aprire:
$2.51
Volume 24 ore:
63,974
Relative Volume:
0.38
Capitalizzazione di mercato:
$17.70M
Reddito:
-
Utile/perdita netta:
$-33.65M
Rapporto P/E:
-0.5687
EPS:
-4.45
Flusso di cassa netto:
$-20.83M
1 W Prestazione:
-1.54%
1M Prestazione:
+17.15%
6M Prestazione:
+66.37%
1 anno Prestazione:
-5.22%
Intervallo 1D:
$2.44
$2.5793
Intervallo di 1 settimana:
$2.2378
$2.7199
Portata 52W:
$1.15
$3.2899
Minerva Neurosciences Inc Stock (NERV) Company Profile
Nome
Minerva Neurosciences Inc
Settore
Industria
Telefono
617-600-7373
Indirizzo
1601 TRAPELO ROAD, WALTHAM, MA
Confronta NERV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
2.5305 | 17.76M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-14 | Iniziato | BTIG Research | Buy |
| 2019-10-02 | Reiterato | Chardan Capital Markets | Buy |
| 2019-09-25 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-31 | Iniziato | H.C. Wainwright | Buy |
| 2017-09-01 | Iniziato | Citigroup | Buy |
| 2017-03-06 | Ripresa | Jefferies | Buy |
| 2016-05-12 | Ripresa | Jefferies | Buy |
Mostra tutto
Minerva Neurosciences Inc Borsa (NERV) Ultime notizie
Key resistance and support levels for Minerva Neurosciences Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risks2025 Trading Recap & AI Forecasted Entry/Exit Points - newser.com
Is Minerva Neurosciences Inc. forming a reversal pattern2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
Minerva Neurosciences Inc. recovery potential after sell offWeekly Risk Report & Consistent Income Trade Ideas - newser.com
How buybacks impact Minerva Neurosciences Inc. stock valueTrade Entry Report & High Conviction Trade Alerts - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.Fed Meeting & Risk Managed Investment Strategies - newser.com
Can technical indicators confirm Minerva Neurosciences Inc.’s reversalJuly 2025 Update & AI Powered Market Entry Strategies - newser.com
Is Minerva Neurosciences Inc. stock overvalued by current metricsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com
How to escape a deep drawdown in Minerva Neurosciences Inc.Price Action & Stock Market Timing Techniques - newser.com
Chart based exit strategy for Minerva Neurosciences Inc.Market Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.July 2025 Decliners & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Minerva Neurosciences Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Is Minerva Neurosciences Inc. a candidate for recovery playMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com
Parkinson Disease Pipeline Drugs 2025 Report: Emerging Drugs, Innovative Therapies, Clinical Trial Updates, and Top Companies - Barchart.com
Would You Accumulate or Wait on JTEKT India Limited (JTEKTINDIA)Earnings Per Share Trends & Free Explosive Trading Growth - earlytimes.in
Is Minerva Neurosciences Inc. stock dividend yield sustainableTrend Reversal & Risk Managed Trade Strategies - newser.com
What analysts say about Minerva Neurosciences Inc 4MNA stockMarket Correction Analysis & Outperform the Market with Aggressive Picks - earlytimes.in
Chart based analysis of Minerva Neurosciences Inc. trendsSell Signal & High Win Rate Trade Tips - newser.com
Is it time to cut losses on Minerva Neurosciences Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
ProShares Trust ProShares UltraShort MSCI Japan Stock Analysis and ForecastStock Market Trends & Small Investment Growth Tips - earlytimes.in
What drives CopAur Minerals Inc RFC4 stock priceInsider Buying Signals & Low Risk Trading Plans - earlytimes.in
What analysts say about Shutterstock Inc stockRetail Trading Trends & Budget Friendly Growth - earlytimes.in
Does Minerva Neurosciences Inc. qualify in momentum factor screeningMarket Trend Report & Reliable Entry Point Alerts - newser.com
What drives Minerva Neurosciences Inc stock priceSell Signals and Alerts & Tap Into the Fastest-Growing Companies - earlytimes.in
Is Farmer Bros. Co. stock a buy on dipsTrade Entry Report & Verified Entry Point Signals - newser.com
Minerva Neurosciences Inc Stock Analysis and ForecastPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in
Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):